CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.31%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$5.17B
AUM Growth
+$808M
(+19%)
Cap. Flow
+$413M
Cap. Flow
% of AUM
8%
Top 10 Holdings %
Top 10 Hldgs %
16.85%
Holding
725
New
51
Increased
415
Reduced
155
Closed
32
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
+$45.5M |
| 2 |
Gilead Sciences
GILD
|
+$39.4M |
| 3 |
GE Aerospace
GE
|
+$36.8M |
| 4 |
Motorola Solutions
MSI
|
+$26M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$24.4M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$55.4M |
| 2 |
Amgen
AMGN
|
+$30M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$23.3M |
| 4 |
Canadian National Railway
CNI
|
+$21.7M |
| 5 |
Becton Dickinson
BDX
|
+$18.5M |
Sector Composition
| 1 | Healthcare | 24.05% |
| 2 | Financials | 13.76% |
| 3 | Technology | 12.92% |
| 4 | Communication Services | 9.3% |
| 5 | Consumer Staples | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Exelon
EXC
$43.5B
| $2.61M | 0.05% |
101,724
+19,481
| +24% | +$500K |
|
377
Norfolk Southern
NSC
$61.3B
| $2.58M | 0.05% |
23,035
+4,521
| +24% | +$506K |
|
378
Theravance Biopharma
TBPH
$693M
| $2.58M | 0.05% |
70,000
-5,000
| -7% | -$184K |
|
379
Centene
CNC
$15.3B
| $2.58M | 0.05% |
72,334
+11,672
| +19% | +$416K |
|
380
Hawaiian Electric Industries
HE
$2.05B
| $2.57M | 0.05% |
77,133
-592
| -0.8% | -$19.7K |
|
381
Enbridge
ENB
$105B
| $2.56M | 0.05% |
61,327
+29,271
| +91% | +$1.22M |
|
382
TC Energy
TRP
$53.9B
| $2.55M | 0.05% |
55,488
+7,004
| +14% | +$322K |
|
383
Baxter International
BAX
$12.6B
| $2.54M | 0.05% |
48,963
+8,290
| +20% | +$430K |
|
|
RVNC
384
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.54M | 0.05% |
122,000
+55,000
| +82% | +$1.14M |
|
385
Zoetis
ZTS
$66.4B
| $2.53M | 0.05% |
47,336
+9,281
| +24% | +$495K |
|
386
Whirlpool
WHR
$5.24B
| $2.48M | 0.05% |
14,466
-25,463
| -64% | -$4.36M |
|
387
Dell
DELL
$82B
| $2.48M | 0.05% |
137,741
+15,027
| +12% | +$270K |
|
388
PACCAR
PCAR
$51.2B
| $2.45M | 0.05% |
54,711
+9,190
| +20% | +$412K |
|
389
Cencora
COR
$57.9B
| $2.44M | 0.05% |
27,519
+10,933
| +66% | +$968K |
|
390
DaVita
DVA
$9.77B
| $2.43M | 0.05% |
35,800
+6,040
| +20% | +$410K |
|
|
ICPT
391
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.43M | 0.05% |
21,500
| – | – |
|
392
Cardinal Health
CAH
$36B
| $2.43M | 0.05% |
29,748
+4,788
| +19% | +$390K |
|
393
Sociedad Química y Minera de Chile
SQM
$11.8B
| $2.41M | 0.05% |
+70,000
| New | +$2.41M |
|
394
Public Storage
PSA
$50.9B
| $2.4M | 0.05% |
10,980
+2,312
| +27% | +$506K |
|
|
SIOX
395
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $2.39M | 0.05% |
20,000
+8,750
| +78% | +$1.05M |
|
396
TherapeuticsMD
TXMD
$12.5M
| $2.38M | 0.05% |
6,600
+3,600
| +120% | +$1.3M |
|
397
SBA Communications
SBAC
$20.6B
| $2.37M | 0.05% |
19,664
-12,134
| -38% | -$1.46M |
|
398
Sherwin-Williams
SHW
$90.1B
| $2.36M | 0.05% |
22,833
-17,208
| -43% | -$1.78M |
|
399
Canadian Natural Resources
CNQ
$64.3B
| $2.35M | 0.05% |
147,126
-4,780
| -3% | -$76.4K |
|
|
FL
400
DELISTED
Foot Locker
FL
| $2.34M | 0.05% |
31,235
+16,000
| +105% | +$1.2M |
|